⌘K

Login Start Free

Home/Filings/4/0000899243-22-021801

4//SEC Filing

Morris Arlene 4

Accession 0000899243-22-021801

CIK 0001590750other

View on SEC.gov Company Profile

Filed

Jun 9, 8:00 PM ET

Accepted

Jun 10, 7:30 AM ET

Size

5.7 KB

Accession

0000899243-22-021801

Insider Transaction Report

Form 4

Period: 2022-06-08

Viridian Therapeutics, Inc.\DEVRDN

Director

Transactions

Award
Stock Option (Right to Buy)
2022-06-08+12,500→ 12,500 total
Exercise: $12.31Exp: 2032-06-08→ Common Stock (12,500 underlying)

Footnotes (1)

[F1]The option vests in full upon the earlier to occur of (i) June 8, 2023 or (ii) the Issuer's 2023 annual meeting of stockholders, subject to Reporting Person's continued service on the Board.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Viridian Therapeutics, Inc.\DE

CIK 0001590750

Entity typeother

Related Parties

1

filerCIK 0001362520

Filing Metadata

Form type: 4
Filed: Jun 9, 8:00 PM ET
Accepted: Jun 10, 7:30 AM ET
Size: 5.7 KB

View on SEC.gov